U.S. Senate Finance Committee Chair Ron Wyden (D-OR) issued a release on 18 January 2022 regarding his continued investigation into the tax practices of multinational pharmaceutical companies to abuse tax havens and avoid paying U.S. tax.

---

Wyden Continues Investigation Into Big Pharma Tax Practices

Following letter to AbbVie, Wyden requests information from Bristol Myers Squibb

Washi…

Continue Reading